Next Article in Journal
The Pedicled Myocutaneous Flap as a Choice Reconstructive Technique for Immediate Adjuvant Brachytherapy in Sarcoma Treatment
Previous Article in Journal
Report from the 13th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; September 8–10, 2011
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 19
Issue 6
10.3747/co.19.1128
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations

by
S. L’Espérance
1,
F. Vincent
2,*,
M. Gaudreault
3,
J.A. Ouellet
4,
M. Li
5,
A. Tosikyan
6,
S. Goulet
7 and
the Comité de l’évolution des Pratiques en Oncologie
1
Comité de l’évolution des Pratiques en Oncologie, Quebec City, QC, Canada
2
Department of Radiation Oncology, Pavillon Sainte-Marie (CSSS de Trois-Rivières) Trois-Rivières, QC, Canada
3
Department of Radiation Oncology, Hôtel-Dieu de Québec (CHU de Québec), Quebec City, QC, Canada
4
Department of Orthopedic Surgery, Montreal General Hospital (McGill University Health Centre), Montreal, QC, Canada
5
Department of Surgery, Hôpital Maisonneuve–Rosemont, Montreal, QC, Canada
6
Department of Haematology and Oncology, Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada
7
Direction Québécoise de Cancérologie, Ministère de la Santé et des Services Sociaux, Quebec City, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2012, 19(6), 478-490; https://doi.org/10.3747/co.19.1128
Submission received: 9 September 2012 / Revised: 7 October 2012 / Accepted: 4 November 2012 / Published: 1 December 2012

Abstract

Background: Metastatic spinal cord compression (MSCC) is an oncologic emergency that, unless diagnosed early and treated appropriately, can lead to permanent neurologic impairment. After an analysis of relevant studies evaluating the effectiveness of various treatment modalities, the Comité de l’évolution des pratiques en oncologie (CEPO) made recommendations on MSCC management. Method: A review of the scientific literature published up to February 2011 considered only phase II and III trials that included assessment of neurologic function. A total of 26 studies were identified. Recommendations: Considering the evidence available to date, CEPO recommends that (1) cancer patients with MSCC be treated by a specialized multidisciplinary team. (2) dexamethasone 16 mg daily be administered to symptomatic patients as soon as MSCC is diagnosed or suspected. (3) high-loading-dose corticosteroids be avoided. (4) histopathologic diagnosis and scores from scales evaluating prognosis and spinal instability be considered before treatment. (5) corticosteroids and chemotherapy with radiotherapy be offered to patients with spinal cord compression caused by myeloma, lymphoma, or germ cell tumour without sign of spinal instability or compression by bone fragment. (6) short-course radiotherapy be administered to patients with spinal cord compression and short life expectancy. (7) long-course radiotherapy be administered to patients with inoperable spinal cord compression and good life expectancy. (8) decompressive surgery followed by long-course radiotherapy be offered to appropriate symptomatic MSCC patients (including spinal instability, displacement of vertebral fragment); and (9) patients considered for surgery have a life expectancy of at least 3–6 months.
Keywords: metastatic spinal cord compression; corticotherapy; dexamethasone; radiotherapy; surgery; clinical guidelines metastatic spinal cord compression; corticotherapy; dexamethasone; radiotherapy; surgery; clinical guidelines

Share and Cite

MDPI and ACS Style

L’Espérance, S.; Vincent, F.; Gaudreault, M.; Ouellet, J.A.; Li, M.; Tosikyan, A.; Goulet, S.; , the Comité de l’évolution des Pratiques en Oncologie. Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations. Curr. Oncol. 2012, 19, 478-490. https://doi.org/10.3747/co.19.1128

AMA Style

L’Espérance S, Vincent F, Gaudreault M, Ouellet JA, Li M, Tosikyan A, Goulet S, the Comité de l’évolution des Pratiques en Oncologie. Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations. Current Oncology. 2012; 19(6):478-490. https://doi.org/10.3747/co.19.1128

Chicago/Turabian Style

L’Espérance, S., F. Vincent, M. Gaudreault, J.A. Ouellet, M. Li, A. Tosikyan, S. Goulet, and the Comité de l’évolution des Pratiques en Oncologie. 2012. "Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations" Current Oncology 19, no. 6: 478-490. https://doi.org/10.3747/co.19.1128

APA Style

L’Espérance, S., Vincent, F., Gaudreault, M., Ouellet, J. A., Li, M., Tosikyan, A., Goulet, S., & , the Comité de l’évolution des Pratiques en Oncologie. (2012). Treatment of Metastatic Spinal Cord Compression: cepo Review and Clinical Recommendations. Current Oncology, 19(6), 478-490. https://doi.org/10.3747/co.19.1128

Article Metrics

Back to TopTop